BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siebold C, Hansen BE, Wyer JR, Harlos K, Esnouf RE, Svejgaard A, Bell JI, Strominger JL, Jones EY, Fugger L. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy. Proc Natl Acad Sci U S A 2004;101:1999-2004. [PMID: 14769912 DOI: 10.1073/pnas.0308458100] [Cited by in Crossref: 103] [Cited by in F6Publishing: 89] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Taheri S. The Immune Basis of Narcolepsy. Sleep Medicine Clinics 2017;12:279-87. [DOI: 10.1016/j.jsmc.2017.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
2 Ivansson EL, Magnusson JJ, Magnusson PKE, Erlich HA, Gyllensten UB. MHC loci affecting cervical cancer risk: distinguishing the effects of HLA-DQB1 and non-HLA genes TNF, LTA, TAP1 and TAP2. Genes Immun 2008;9:613-23. [DOI: 10.1038/gene.2008.58] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
3 Shoshan SH, Admon A. MHC-bound antigens and proteomics for novel target discovery. Pharmacogenomics 2004;5:845-59. [DOI: 10.1517/14622416.5.7.845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
4 Miyadera H, Bungener LB, Kusano S, Yokoyama S, Tokunaga K, Hepkema BG. Questionable expression of unstable DQ heterodimer containing HLA-DQA1*01:07. Tissue Antigens 2015;86:413-8. [PMID: 26555242 DOI: 10.1111/tan.12686] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511. [PMID: 17292770 DOI: 10.1016/S0140-6736(07)60237-2] [Cited by in Crossref: 471] [Cited by in F6Publishing: 147] [Article Influence: 31.4] [Reference Citation Analysis]
6 Dauvilliers Y, Arnulf I. Narcolepsie avec cataplexie. Revue Neurologique 2008;164:634-45. [DOI: 10.1016/j.neurol.2007.08.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl) 2004;82:510-29. [PMID: 15175861 DOI: 10.1007/s00109-004-0552-1] [Cited by in Crossref: 215] [Cited by in F6Publishing: 194] [Article Influence: 11.9] [Reference Citation Analysis]
8 Miyasaka T, Takeshima SN, Sentsui H, Aida Y. Identification and diversity of bovine major histocompatibility complex class II haplotypes in Japanese Black and Holstein cattle in Japan. J Dairy Sci 2012;95:420-31. [PMID: 22192221 DOI: 10.3168/jds.2011-4621] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
9 Gaseitsiwe S, Valentini D, Ahmed R, Mahdavifar S, Magalhaes I, Zerweck J, Schutkowski M, Gautherot E, Montero F, Ehrnst A, Reilly M, Maeurer M. Major histocompatibility complex class II molecule-human immunodeficiency virus peptide analysis using a microarray chip. Clin Vaccine Immunol 2009;16:567-73. [PMID: 19225081 DOI: 10.1128/CVI.00441-08] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Delgado JC, Baena A, Thim S, Goldfeld AE. Aspartic acid homozygosity at codon 57 of HLA-DQ beta is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol 2006;176:1090-7. [PMID: 16393997 DOI: 10.4049/jimmunol.176.2.1090] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
11 Cortés A, Coral J, Mclachlan C, Benítez R, Pinilla L. Planar molecular arrangements aid the design of MHC class II binding peptides. Mol Biol 2017;51:465-73. [DOI: 10.1134/s002689331702008x] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Behrens M, Papadopoulos GK, Moustakas A, Smart M, Luthra H, David CS, Taneja V. Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice. Arthritis Rheum 2011;63:1552-61. [PMID: 21305521 DOI: 10.1002/art.30260] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Black JL, Silber MH, Krahn LE, Avula RK, Walker DL, Pankratz VS, Fredrickson PA, Slocumb NL. Studies of Humoral Immunity to Preprohypocretin in Human Leukocyte Antigen DQB1*0602–Positive Narcoleptic Subjects with Cataplexy. Biological Psychiatry 2005;58:504-9. [DOI: 10.1016/j.biopsych.2005.04.026] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
14 Zavala-Ruiz Z, Strug I, Walker BD, Norris PJ, Stern LJ. A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. Proc Natl Acad Sci U S A 2004;101:13279-84. [PMID: 15331779 DOI: 10.1073/pnas.0403371101] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
15 Zhao LP, Papadopoulos GK, Moustakas AK, Bondinas GP, Carlsson A, Larsson HE, Ludvigsson J, Marcus C, Persson M, Samuelsson U, Wang R, Pyo CW, Geraghty DE, Lernmark Å. Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden. Sci Rep 2021;11:8821. [PMID: 33893332 DOI: 10.1038/s41598-021-86229-8] [Reference Citation Analysis]
16 Donaldson PT, Daly AK, Henderson J, Graham J, Pirmohamed M, Bernal W, Day CP, Aithal GP. Human leucocyte antigen class II genotype in susceptibility and resistance to co-amoxiclav-induced liver injury. J Hepatol. 2010;53:1049-1053. [PMID: 20800921 DOI: 10.1016/j.jhep.2010.05.033] [Cited by in Crossref: 106] [Cited by in F6Publishing: 89] [Article Influence: 8.8] [Reference Citation Analysis]
17 Rao M, Zhenjiang L, Meng Q, Sinclair G, Dodoo E, Maeurer M. Mutant Epitopes in Cancer. In: Zitvogel L, Kroemer G, editors. Oncoimmunology. Cham: Springer International Publishing; 2018. pp. 41-67. [DOI: 10.1007/978-3-319-62431-0_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
18 Benkert P, Biasini M, Schwede T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 2011;27:343-50. [PMID: 21134891 DOI: 10.1093/bioinformatics/btq662] [Cited by in Crossref: 1206] [Cited by in F6Publishing: 1010] [Article Influence: 100.5] [Reference Citation Analysis]
19 Miyadera H, Tokunaga K. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism. J Hum Genet. 2015;60:697-702. [PMID: 26290149 DOI: 10.1038/jhg.2015.100] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 5.6] [Reference Citation Analysis]
20 Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol 2006;176:1988-98. [PMID: 16424231 DOI: 10.4049/jimmunol.176.3.1988] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.4] [Reference Citation Analysis]
21 Sethi DK, Schubert DA, Anders AK, Heroux A, Bonsor DA, Thomas CP, Sundberg EJ, Pyrdol J, Wucherpfennig KW. A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC. J Exp Med 2011;208:91-102. [PMID: 21199956 DOI: 10.1084/jem.20100725] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
22 Ollila HM, Fernandez-Vina M, Mignot E. HLA-DQ allele competition in narcolepsy: a comment on Tafti et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2015;38:147-51. [PMID: 25325462 DOI: 10.5665/sleep.4342] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
23 Logunova NN, Viret C, Pobezinsky LA, Miller SA, Kazansky DB, Sundberg JP, Chervonsky AV. Restricted MHC-peptide repertoire predisposes to autoimmunity. J Exp Med 2005;202:73-84. [PMID: 15998789 DOI: 10.1084/jem.20050198] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
24 Jiang W, Birtley JR, Hung SC, Wang W, Chiou SH, Macaubas C, Kornum B, Tian L, Huang H, Adler L, Weaver G, Lu L, Ilstad-Minnihan A, Somasundaram S, Ayyangar S, Davis MM, Stern LJ, Mellins ED. In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls. Nat Commun 2019;10:5247. [PMID: 31748512 DOI: 10.1038/s41467-019-13234-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
25 Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, Lush MJ, Povey S, Talbot CC, Wright MW. Gene map of the extended human MHC. Nat Rev Genet. 2004;5:889-899. [PMID: 15573121 DOI: 10.1038/nrg1489] [Cited by in Crossref: 715] [Cited by in F6Publishing: 641] [Article Influence: 39.7] [Reference Citation Analysis]
26 Fontana A, Gast H, Reith W, Recher M, Birchler T, Bassetti CL. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain. 2010;133:1300-1311. [PMID: 20403960 DOI: 10.1093/brain/awq086] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 5.2] [Reference Citation Analysis]
27 Wang B, Li J, Cheng X, Zhou Q, Yang J, Zhang M, Chen H, Li J. NIPS, a 3D network-integrated predictor of deleterious protein SAPs, and its application in cancer prognosis. Sci Rep 2018;8:6021. [PMID: 29662108 DOI: 10.1038/s41598-018-24286-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Kornum BR, Burgdorf KS, Holm A, Ullum H, Jennum P, Knudsen S. Absence of autoreactive CD4 + T-cells targeting HLA-DQA1*01:02/DQB1*06:02 restricted hypocretin/orexin epitopes in narcolepsy type 1 when detected by EliSpot. Journal of Neuroimmunology 2017;309:7-11. [DOI: 10.1016/j.jneuroim.2017.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
29 Gaseitsiwe S, Maeurer MJ. Identification of MHC class II binding peptides: microarray and soluble MHC class II molecules. Methods Mol Biol 2009;524:417-26. [PMID: 19377962 DOI: 10.1007/978-1-59745-450-6_30] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Sospedra M, Muraro PA, Stefanová I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R. Redundancy in antigen-presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR2 haplotype. J Immunol 2006;176:1951-61. [PMID: 16424227 DOI: 10.4049/jimmunol.176.3.1951] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
31 Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE. The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019;20:83-93. [PMID: 30546103 DOI: 10.1038/s41583-018-0097-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 18.7] [Reference Citation Analysis]
32 Parry CS, Brooks BR. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes. Biol Direct 2008;3:42. [PMID: 18854049 DOI: 10.1186/1745-6150-3-42] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
33 Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015;14:318-28. [PMID: 25728441 DOI: 10.1016/S1474-4422(14)70218-2] [Cited by in Crossref: 107] [Cited by in F6Publishing: 34] [Article Influence: 15.3] [Reference Citation Analysis]
34 Reddy Chichili VP, Kumar V, Sivaraman J. Linkers in the structural biology of protein-protein interactions. Protein Sci 2013;22:153-67. [PMID: 23225024 DOI: 10.1002/pro.2206] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 17.1] [Reference Citation Analysis]
35 Zhou Z, Jensen PE. Structural Characteristics of HLA-DQ that May Impact DM Editing and Susceptibility to Type-1 Diabetes. Front Immunol 2013;4:262. [PMID: 24009614 DOI: 10.3389/fimmu.2013.00262] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
36 Andreatta M, Nielsen M. Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign. Immunology 2012;136:306-11. [PMID: 22352343 DOI: 10.1111/j.1365-2567.2012.03579.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
37 Attaf M, Legut M, Cole DK, Sewell AK. The T cell antigen receptor: the Swiss army knife of the immune system. Clin Exp Immunol 2015;181:1-18. [PMID: 25753381 DOI: 10.1111/cei.12622] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
38 Mohammadi S, Dolatshahi M, Zare-shahabadi A, Rahmani F. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research 2019;1718:212-22. [DOI: 10.1016/j.brainres.2019.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
39 Hansen BE, Nielsen CH, Madsen HO, Ryder LP, Jakobsen BK, Svejgaard A. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity. Tissue Antigens 2011;77:229-34. [DOI: 10.1111/j.1399-0039.2010.01614.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Ling F, Wei LQ, Wang T, Wang HB, Zhuo M, Du HL, Wang JF, Wang XN. Characterization of the major histocompatibility complex class II DOB, DPB1, and DQB1 alleles in cynomolgus macaques of Vietnamese origin. Immunogenetics 2011;63:155-66. [PMID: 21132285 DOI: 10.1007/s00251-010-0498-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
41 Cocco E, Sardu C, Pieroni E, Valentini M, Murru R, Costa G, Tranquilli S, Frau J, Coghe G, Carboni N, Floris M, Contu P, Marrosu MG. HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia. PLoS One 2012;7:e33972. [PMID: 22509268 DOI: 10.1371/journal.pone.0033972] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
42 Liu R, Jiang W, Mellins ED. Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA). Cell Mol Immunol 2021;18:1847-60. [PMID: 34117370 DOI: 10.1038/s41423-021-00717-5] [Reference Citation Analysis]
43 Carignano HA, Beribe MJ, Caffaro ME, Amadio A, Nani JP, Gutierrez G, Alvarez I, Trono K, Miretti MM, Poli MA. BOLA-DRB3 gene polymorphisms influence bovine leukaemia virus infection levels in Holstein and Holstein × Jersey crossbreed dairy cattle. Anim Genet 2017;48:420-30. [DOI: 10.1111/age.12566] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
44 Masoudi S, Ploen D, Kunz K, Hildt E. The adjuvant component α-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy. Vaccine 2014;32:2980-8. [PMID: 24721530 DOI: 10.1016/j.vaccine.2014.03.085] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
45 Mignot EJ. History of narcolepsy at Stanford University. Immunol Res 2014;58:315-39. [PMID: 24825774 DOI: 10.1007/s12026-014-8513-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
46 Akers NK, Curry JD, Conde L, Bracci PM, Smith MT, Skibola CF. Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma 2011;52:53-8. [PMID: 21133715 DOI: 10.3109/10428194.2010.532888] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
47 De la Herrán-Arita AK, Kornum BR, Mahlios J, Jiang W, Lin L, Hou T, Macaubas C, Einen M, Plazzi G, Crowe C, Newell EW, Davis MM, Mellins ED, Mignot E. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med 2013;5:216ra176. [PMID: 24353159 DOI: 10.1126/scitranslmed.3007762] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
48 Ravel JM, Mignot EJM. [Narcolepsy: From the discovery of a wake promoting peptide to autoimmune T cell biology and molecular mimicry with flu epitopes]. Biol Aujourdhui 2019;213:87-108. [PMID: 31829930 DOI: 10.1051/jbio/2019026] [Reference Citation Analysis]
49 Ramberger M, Högl B, Stefani A, Mitterling T, Reindl M, Lutterotti A. CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1. Sleep 2017;40. [PMID: 28364420 DOI: 10.1093/sleep/zsw070] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
50 Yeturu K, Utriainen T, Kemp GJ, Chandra N. An automated framework for understanding structural variations in the binding grooves of MHC class II molecules. BMC Bioinformatics 2010;11 Suppl 1:S55. [PMID: 20122230 DOI: 10.1186/1471-2105-11-S1-S55] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Dimitrov I, Doytchinova I. Peptide Binding Prediction to Five Most Frequent HLA-DQ Proteins - a Proteochemometric Approach. Mol Inform 2015;34:467-76. [PMID: 27490390 DOI: 10.1002/minf.201400150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
52 Bergseng E, Xia J, Kim CY, Khosla C, Sollid LM. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease-associated HLA-DQ2 molecule. J Biol Chem 2005;280:21791-6. [PMID: 15826953 DOI: 10.1074/jbc.M501558200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
53 Lérias JR, Paraschoudi G, de Sousa E, Martins J, Condeço C, Figueiredo N, Carvalho C, Dodoo E, Castillo-Martin M, Beltrán A, Ligeiro D, Rao M, Zumla A, Maeurer M. Microbes as Master Immunomodulators: Immunopathology, Cancer and Personalized Immunotherapies. Front Cell Dev Biol 2019;7:362. [PMID: 32039196 DOI: 10.3389/fcell.2019.00362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
54 Magira EE, Papasteriades C, Kanterakis S, Toubis M, Roussos C, Monos DS. HLA-A and HLA-DRB1 amino acid polymorphisms are associated with susceptibility and protection to pulmonary tuberculosis in a Greek population. Human Immunology 2012;73:641-6. [DOI: 10.1016/j.humimm.2012.03.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
55 Hashemi S, Fernandez Martinez JL, Saligan L, Sonis S. Exploring Genetic Attributions Underlying Radiotherapy-Induced Fatigue in Prostate Cancer Patients. Journal of Pain and Symptom Management 2017;54:326-39. [DOI: 10.1016/j.jpainsymman.2017.04.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Bondinas GP, Moustakas AK, Papadopoulos GK. The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function. Immunogenetics 2007;59:539-53. [DOI: 10.1007/s00251-007-0224-8] [Cited by in Crossref: 105] [Cited by in F6Publishing: 99] [Article Influence: 7.0] [Reference Citation Analysis]
57 Reading PJ. Update on narcolepsy. J Neurol 2019;266:1809-15. [DOI: 10.1007/s00415-019-09310-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Quaratino S, Badami E, Pang YY, Bartok I, Dyson J, Kioussis D, Londei M, Maiuri L. Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat Med 2004;10:920-6. [PMID: 15311276 DOI: 10.1038/nm1092] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
59 Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007;68:12-25. [PMID: 17207708 DOI: 10.1016/j.humimm.2006.10.003] [Cited by in Crossref: 111] [Cited by in F6Publishing: 109] [Article Influence: 6.9] [Reference Citation Analysis]
60 Miyamura N, Murata Y, Taketa K, Ichihara Y, Matsumura T, Tokunaga H, Matsumoto K, Sakakida M, Araki E. A case of insulin autoimmune syndrome with HLA DRB1*0404: impact on the hypothesis for the molecular pathogenesis involving DRB1 molecules. Diabet Med 2006;23:104-5. [DOI: 10.1111/j.1464-5491.2006.01775.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
61 Miyadera H, Ohashi J, Lernmark Å, Kitamura T, Tokunaga K. Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA. J Clin Invest 2015;125:275-91. [PMID: 25485681 DOI: 10.1172/JCI74961] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
62 Rayment R, Kooij TW, Zhang W, Siebold C, Murphy MF, Allen D, Willcox N, Roberts DJ. Evidence for the specificity for platelet HPA-1a alloepitope and the presenting HLA-DR52a of diverse antigen-specific helper T cell clones from alloimmunized mothers. J Immunol 2009;183:677-86. [PMID: 19535639 DOI: 10.4049/jimmunol.0801473] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
63 Moutou KA, Mamuris Z, Firme T, Kontou M, Sarafidou T, Stoumboudi MT. Patterns of variability at the major histocompatibility class I and class II loci in populations of the endangered cyprinid Ladigesocypris ghigii. Conserv Genet 2011;12:1159-71. [DOI: 10.1007/s10592-011-0217-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
64 Zhao LP, Papadopoulos GK, Kwok WW, Moustakas AK, Bondinas GP, Carlsson A, Elding Larsson H, Ludvigsson J, Marcus C, Samuelsson U, Wang R, Pyo CW, Nelson WC, Geraghty DE, Lernmark Å. Next-Generation HLA Sequence Analysis Uncovers Seven HLA-DQ Amino Acid Residues and Six Motifs Resistant to Childhood Type 1 Diabetes. Diabetes 2020;69:2523-35. [PMID: 32868339 DOI: 10.2337/db20-0374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F. The type 1 diabetes - HLA susceptibility interactome--identification of HLA genotype-specific disease genes for type 1 diabetes. PLoS One 2010;5:e9576. [PMID: 20221424 DOI: 10.1371/journal.pone.0009576] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
66 Etzensperger R, Mcmahon RM, Jones EY, Fugger L. Dissection of the multiple sclerosis associated DR2 haplotype. Journal of Autoimmunity 2008;31:201-7. [DOI: 10.1016/j.jaut.2008.04.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
67 Cho M, Ko S, Oh H, Heo Y, Kwon O. HLA-DQB1*05:06, a novel HLA-DQB1*05 allele identified by sequence-based typing. Tissue Antigens 2011;77:344-6. [DOI: 10.1111/j.1399-0039.2010.01630.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
68 Justesen S, Harndahl M, Lamberth K, Nielsen LL, Buus S. Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res 2009;5:2. [PMID: 19416502 DOI: 10.1186/1745-7580-5-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
69 Kumar S, Sagili H. Etiopathogenesis and neurobiology of narcolepsy: a review. J Clin Diagn Res 2014;8:190-5. [PMID: 24701532 DOI: 10.7860/JCDR/2014/7295.4057] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
70 Woelfing B, Traulsen A, Milinski M, Boehm T. Does intra-individual major histocompatibility complex diversity keep a golden mean? Philos Trans R Soc Lond B Biol Sci 2009;364:117-28. [PMID: 18926972 DOI: 10.1098/rstb.2008.0174] [Cited by in Crossref: 119] [Cited by in F6Publishing: 110] [Article Influence: 9.2] [Reference Citation Analysis]
71 Jones EY, Fugger L, Strominger JL, Siebold C. MHC class II proteins and disease: a structural perspective. Nat Rev Immunol 2006;6:271-82. [PMID: 16557259 DOI: 10.1038/nri1805] [Cited by in Crossref: 261] [Cited by in F6Publishing: 254] [Article Influence: 16.3] [Reference Citation Analysis]
72 Guturu H, Chinchali S, Clarke SL, Bejerano G. Erosion of Conserved Binding Sites in Personal Genomes Points to Medical Histories. PLoS Comput Biol 2016;12:e1004711. [PMID: 26845687 DOI: 10.1371/journal.pcbi.1004711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Egorov IK. Mouse models of efficient and inefficient anti-tumor immunity, with emphasis on minimal residual disease and tumor escape. Cancer Immunol Immunother 2006;55:1-22. [DOI: 10.1007/s00262-005-0007-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
74 Wiendl H, Gross CC, Bauer J, Merkler D, Prat A, Liblau R. Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases. Nat Rev Neurol 2021;17:433-47. [PMID: 34050331 DOI: 10.1038/s41582-021-00496-7] [Reference Citation Analysis]
75 Qiu CL, Yang GB, Yu K, Li Y, Li XL, Liu Q, Zhao H, Xing H, Shao Y. Characterization of the major histocompatibility complex class II DQB (MhcMamu-DQB1) alleles in a cohort of Chinese rhesus macaques (Macaca mulatta). Hum Immunol 2008;69:513-21. [PMID: 18582516 DOI: 10.1016/j.humimm.2008.05.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
76 Eerligh P, van Lummel M, Zaldumbide A, Moustakas AK, Duinkerken G, Bondinas G, Koeleman BP, Papadopoulos GK, Roep BO. Functional consequences of HLA-DQ8 homozygosity versus heterozygosity for islet autoimmunity in type 1 diabetes. Genes Immun 2011;12:415-27. [PMID: 21562577 DOI: 10.1038/gene.2011.24] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
77 Mignot E. Excessive daytime sleepiness: Population and etiology versus nosology. Sleep Medicine Reviews 2008;12:87-94. [DOI: 10.1016/j.smrv.2007.12.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
78 Simmons DP, Kafetzi ML, Wood I, Macaskill PC, Milford EL, Guleria I. Antibodies against HLA-DP recognize broadly expressed epitopes. Hum Immunol 2016;77:1128-39. [PMID: 27664843 DOI: 10.1016/j.humimm.2016.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
79 Sidney J, Steen A, Moore C, Ngo S, Chung J, Peters B, Sette A. Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population. J Immunol 2010;185:4189-98. [PMID: 20810981 DOI: 10.4049/jimmunol.1001006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.2] [Reference Citation Analysis]
80 Caillat-zucman S. Molecular mechanisms of HLA association with autoimmune diseases. Tissue Antigens 2009;73:1-8. [DOI: 10.1111/j.1399-0039.2008.01167.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
81 Hillson R. Fatigue and tiredness in diabetes. Pract Diab 2020;37:45-6. [DOI: 10.1002/pdi.2261] [Reference Citation Analysis]
82 Zayed H. Genetic Epidemiology of Type 1 Diabetes in the 22 Arab Countries. Curr Diab Rep 2016;16:37. [PMID: 26983625 DOI: 10.1007/s11892-016-0736-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
83 Fallang L, Bergseng E, Hotta K, Berg-larsen A, Kim C, Sollid LM. Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation. Nat Immunol 2009;10:1096-101. [DOI: 10.1038/ni.1780] [Cited by in Crossref: 99] [Cited by in F6Publishing: 86] [Article Influence: 7.6] [Reference Citation Analysis]
84 Miki D, Ochi H, Takahashi A, Hayes CN, Urabe Y, Abe H, Kawaoka T, Tsuge M, Hiraga N, Imamura M, Kawakami Y, Aikata H, Takahashi S, Akuta N, Suzuki F, Ikeda K, Kumada H, Karino Y, Toyota J, Tsunoda T, Kubo M, Kamatani N, Nakamura Y, Chayama K. HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study. PLoS One 2013;8:e84226. [PMID: 24376798 DOI: 10.1371/journal.pone.0084226] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
85 Královicová J, Houngninou-Molango S, Krämer A, Vorechovsky I. Branch site haplotypes that control alternative splicing. Hum Mol Genet 2004;13:3189-202. [PMID: 15496424 DOI: 10.1093/hmg/ddh334] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
86 Kachooei-Mohaghegh-Yaghoobi L, Rezaei-Rad F, Sadeghniiat-Haghighi K, Zamani M. The impact of the HLA DQB1 gene and amino acids on the development of narcolepsy. Int J Neurosci 2020;:1-8. [PMID: 33045884 DOI: 10.1080/00207454.2020.1835903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Hardie RA, Luo M, Bruneau B, Knight E, Nagelkerke NJ, Kimani J, Wachihi C, Ngugi EN, Plummer FA. Human leukocyte antigen-DQ alleles and haplotypes and their associations with resistance and susceptibility to HIV-1 infection. AIDS 2008;22:807-16. [PMID: 18427198 DOI: 10.1097/QAD.0b013e3282f51b71] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
88 de Sousa E, Ligeiro D, Lérias JR, Zhang C, Agrati C, Osman M, El-Kafrawy SA, Azhar EI, Ippolito G, Wang FS, Zumla A, Maeurer M. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. Int J Infect Dis 2020;98:454-9. [PMID: 32693089 DOI: 10.1016/j.ijid.2020.07.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
89 Zakharova MY, Belyanina TA, Sokolov AV, Kiselev IS, Mamedov AE. The Contribution of Major Histocompatibility Complex Class II Genes to an Association with Autoimmune Diseases. Acta Naturae 2019;11:4-12. [PMID: 31993230 DOI: 10.32607/20758251-2019-11-4-4-12] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
90 Faraco J, Mignot E. Immunological and Genetic Aspects of Narcolepsy. Sleep Med Res 2011;2:39-47. [DOI: 10.17241/smr.2011.2.2.39] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Overeem S, Black JL 3rd, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev 2008;12:95-107. [PMID: 18291691 DOI: 10.1016/j.smrv.2007.07.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]